A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2011
10/05/2011	EP2371839A1 Peptidomimetic protease inhibitors
10/05/2011	EP2371838A1 Novel immunogenic compositions for the prevention and treatment of meningococcal disease
10/05/2011	EP2371837A1 Novel immunogenic compositions for the prevention and treatment of meningococcal disease
10/05/2011	EP2371836A1 Novel immunogenic compositions for the prevention and treatment of meningococcal disease
10/05/2011	EP2371396A1 Truncated fragments of alpha synuclein in lewy body disease
10/05/2011	EP2371379A2 New formulation for increasing bioavailability of neurturin
10/05/2011	EP2371378A1 Modification of feeding behaviour and weight control by oxyntomodulin
10/05/2011	EP2371377A1 Wound healing agent and composition
10/05/2011	EP2371376A1 Methods and reagents for the diagnosis, prevention and treatment of insulin resistance
10/05/2011	EP2371375A1 Peptide for inhibiting skin aging
10/05/2011	EP2371361A1 Methods to mobilize progenitor/stem cells
10/05/2011	EP2370574A1 Mutants of staphylokinase carrying amino and carboxy-terminal extensions for polyethylene glycol conjugation
10/05/2011	EP2370472A1 Leptin and leptin analog conjugates and uses thereof
10/05/2011	EP2370471A1 Conjugates of neurotensin or neurotensin analogs and uses thereof
10/05/2011	EP2370462A1 Glucagon analogues
10/05/2011	EP2370461A1 Glucagon analogues
10/05/2011	EP2370460A1 Glucagon analogues
10/05/2011	EP2370458A1 Neuregulin peptides and their use
10/05/2011	EP2370453A1 Peptides derived from hmg-coa reductase and cosmetic and/or pharmaceutical composition containing same
10/05/2011	EP2370112A2 Implantable liposome embedded matrix composition, uses thereof, and polycaprolactone praticles as scaffolds for tissue regeneration
10/05/2011	EP2370109A1 Proliferation-associated modulation of the splicing of the integrin alpha 6 isoforms
10/05/2011	EP2370104A1 Peptides for treatment of obesity
10/05/2011	EP2370093A1 Neuregulin and cardiac stem cells
10/05/2011	EP2370092A1 Modulation of olfml-3 mediated angiogenesis
10/05/2011	EP2370091A2 Compositions and methods relating to mir-31
10/05/2011	EP2370090A1 Treating neoplasms with neurotoxin
10/05/2011	EP2370089A1 Compounds and methods for the treatment of autoimmune and inflammatory disease
10/05/2011	EP2370088A2 Mammalian colostrum derived nanopeptides for broadspectrum viral and recurrent infections with a method of isolation thereof
10/05/2011	EP2370087A2 Methods and compositions for the treatment of fluid retention disorders
10/05/2011	EP2370067A1 Antiviral patch
10/05/2011	EP2370059A1 Pharmaceutical compositions suitable for oral administration of derivatized insulin peptides
10/05/2011	EP2370058A1 Liposomal composition for convection-enhanced delivery to the central nervous centre
10/05/2011	EP2259792B1 Bone morphogenetic proteins for use in treating and preventing neuroblastomas
10/05/2011	EP1971684B1 Chimaeric fusion protein with superior chaperone and folding activities
10/05/2011	EP1923463B1 Cancer-rejection antigen peptide derived from glypican-3 (gpc3) for use in hla-a2-positive patient and pharmaceutical comprising the antigen
10/05/2011	EP1885390B1 Use of peptides derived from the growth factor amp-18 for the treatment of oral mucositis
10/05/2011	EP1848804B1 Anti-muc1 alpha beta antibodies
10/05/2011	EP1664327B1 METHODS OF SCREENING FOR COMPOUNDS THAT MODULATE TAFIa ACTIVITY, COMPOUNDS, AND METHODS OF USING THE COMPOUNDS
10/05/2011	EP1660682B1 ANTISENSE MODULATION OF p38 MITOGEN ACTIVATED PROTEIN KINASE EXPRESSION
10/05/2011	EP1653912B1 Vaccine immunotherapy for immune suppressed patients
10/05/2011	EP1646366B1 Method of preparing mixed formulation of sustained release microspheres by continuous one-step process
10/05/2011	EP1578780B1 Method to increase fibronectin
10/05/2011	EP1562577B1 Acetyl-l-carnitine for the prevention and/or treatment of peripheral neuropathies induced by thalidomide
10/05/2011	EP1492814B1 Interleukin-1-beta derived peptide and its therapeutic application
10/05/2011	EP1406633B1 Enhanced drug delivery in transdermal systems
10/05/2011	EP1395279B1 Use of neublastin polypeptides for treating neuropathic pain
10/05/2011	EP1377680B1 Diagnosis and treatment of breast cancer based upon scn5a
10/05/2011	EP1373296B1 Proteins producing an altered immunogenic response and methods of making and using the same
10/05/2011	EP1355676B1 Method of protecting therapeutic compositions from host-mediated inactivation
10/05/2011	EP1272208B1 Use of vegf 165 and homologues to treat neuron disorders
10/05/2011	EP1267838B1 Proteins deposited onto sparingly soluble biocompatible particles for controlled protein release into a biological environment from a polymer matrix
10/05/2011	EP1133309B1 Composition and methods for neural tissue repair
10/05/2011	EP1017835B1 Cytochrome p450 reductase for the enhancement of p450-based anti-cancer gene therapy
10/05/2011	EP0975762B1 Type-1 ribosome-inactivating protein
10/05/2011	CN1617704B Composition comprising at least one oxazolin for inhibiting langerhans cell migration, and uses thereof
10/05/2011	CN1446227B Novel fibroblast growth factor (FRF23) and method for use
10/05/2011	CN102209784A Periostin-induced pancreatic regeneration
10/05/2011	CN102209558A Pharmaceutical composition utilising combinations of variants of the gonadotropin-liberating hormone (gnrh) as immunogen
10/05/2011	CN102209554A Compositions and methods for the prevention of oxidative degradation of proteins
10/05/2011	CN102209553A Peptide formulations and uses thereof
10/05/2011	CN102209552A Compositions containing interleukin-1 and peptides
10/05/2011	CN102209530A Orally administrable immunostimulant product for aquaculture
10/05/2011	CN102206679A Shuttle vector of vaccinia virus and its application
10/05/2011	CN102206667A Recombinant plasmid pET32a-hIL-23R-CHR and construction and expression thereof
10/05/2011	CN102206660A Engineered protein TAT-VP28 against white spot syndrome virus of shrimp and its preparation and purpose
10/05/2011	CN102206285A Chimeric peptide based on endomorphins 2 and neuropeptides FF, and synthesis and application thereof
10/05/2011	CN102206284A Recombinant human DT388sBAFF immunotoxin and coding gene and use thereof
10/05/2011	CN102206283A Recombinant human PE38sBAFF immunotoxin and coding gene and use thereof
10/05/2011	CN102206281A Fusion protein TETPH, expression vector and construction method thereof
10/05/2011	CN102206276A Humanized antibodies derived from DD-3B6/22, specific for the D-dimer fragment of fibrin
10/05/2011	CN102206272A Method for production of recombinant alpha1-antitrypsin
10/05/2011	CN102206267A Molecular structure and application of tumor necrosis factor receptor 1 proligand assembly domain glycocluster
10/05/2011	CN102206264A O.jingdongensis sp. antibacterial peptide and preparation method and use thereof
10/05/2011	CN102206250A Low hematolysis antimicrobial peptide, pharmaceutical composition and use thereof
10/05/2011	CN102206247A Novel peptides as NS3-serine protease inhibitors of hepatitis C virus
10/05/2011	CN102205128A Antibacterial peptide preservative, antibacterial peptide preparation containing the same, and preparation method for the antibacterial peptide preparation
10/05/2011	CN102205115A Application of ulinastatin serving as rescue auxiliary medicament for toxic shock caused by acute abdomen
10/05/2011	CN102205114A Application of erythropoietin source peptide to preparation of medicament for treating autoimmune disease of nervous system
10/05/2011	CN102205113A Novel application of Jingzhaotoxin
10/05/2011	CN102205112A BMP composition for synergistic induction of ossification differentiation, and application thereof
10/05/2011	CN102205111A Application of agrocybe aegerita galactose agglutinin to preparation of anti-HIV (Human Immunodeficiency Virus) infection medicament
10/05/2011	CN102205110A Application of integrin blocker in preparation of medicaments for treating ocular neovascular diseases
10/05/2011	CN102204898A Method for inducing ovulation by using non-polypeptide cyclic adenosine 3',5'-monophosphate (cAMP) level modulator
10/05/2011	CN102204890A Eptifibatide lyophilized powder injection with superior rehydration
10/05/2011	CN102204889A Degarelix acetate lyophilized powder injection and preparation method thereof
10/05/2011	CN101585866B Polypeptide for regulating activity of FGFR3 and screening method and application thereof
10/05/2011	CN101481404B Zymohydrolysis lactoprotein ferrous complex compound microcapsule iron supplement agent and preparation thereof
10/05/2011	CN101402676B Polyglycols modified disinfection/neutralization endotoxin polypeptide, preparation and uses thereof
10/05/2011	CN101380464B Method for treating a movement disorder
10/05/2011	CN101240033B Fusion protein of insulin secretion accelerating peptide and human serum albumin, and preparation method thereof
10/05/2011	CN101161284B Novel antimicrobial peptides with heparin binding activity
10/05/2011	CN101130058B Emulsion of cyclosporin A for eyes and method of producing the same
10/04/2011	US8032564 System and method for monitoring and analyzing internet traffic
10/04/2011	US8030537 Somatic cloning gene transfer for the production of recombinant proteins, cells and organs
10/04/2011	US8030464 Stabilized bioactive peptides and methods of identification, synthesis, and use
10/04/2011	US8030450 Canine RANKL and methods for preparing and using the same
10/04/2011	US8030448 Polypeptide having collagen-like structure
10/04/2011	US8030445 Glycopeptide derivative
10/04/2011	US8030444 Microbicidal compositions comprising human CD38 polypeptides derived from the extracellular membrane-proximal region
10/04/2011	US8030442 Treatment of injury to the brain by inhibition of acid sensing ion channels

1 ... 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 ... 3163